10A NCAC 41A.0214: Control Measures Hepatitis C

Hepatitis C virus (HCV) is the most common bloodborne infection in the United States. HCV infections can lead to chronic liver disease and are therefore pose a major public health problem. Control measures for HCV, when correctly implemented, can decrease the risk of disease transmission and reduce the risk of chronic liver disease. Early detection is important for preventing transmission from newly infected persons. In addition, recent studies suggest that treatment within the first six months following HCV infection can produce a sustained virologic response rate of 85 percent or higher.

The delivery of health care has the potential to transmit HCV to both health care workers and patients. Outbreaks of HCV infection have occurred in outpatient settings, hemodialysis units, ambulatory surgery facilities, and hospitals.

A public hearing was held on December 19, 2011 at 1 p.m. in the Cardinal Room, located at 5605 Six Forks Road, Raleigh, NC 27609 .

Proposed Rule:	10A NCAC 41A.0214: Control Measures Hepatitis C (Notice Date: 12/01/2011)
Fiscal Note:	10A NCAC 41A.0214 Fiscal Impact
Federal Certification:	N/A
Adopted Rule:	N/A

Public Comments

The public comment period was from December 1, 2011 through January 30, 2012. Comments for this rule will not be accepted after January 30, 2012.